Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Recruiting · NCT04755764 · Observational (researchers observe without assigning treatment) · Lead sponsor: Marshall University
View the official record on ClinicalTrials.gov →Interventions studied
AtenololLabetalolNifedipine
What this trial is about
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
Who can take part
Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
- English speaking
- 18-45 years old.
- Willing to provide informed consent
- Gestational age prior to 15 weeks gestation
Exclusion criteria
- Non-English speaking patients, patients
- \<18 years old or \>45 years old
- Not willing or able to provide consent
- Gestational age \>15 weeks
Where it is running
1 location listed across 1 US state.
- Maternal Hypertension Center at Cabell Huntington Hospital - Huntington, West Virginia, United States